Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the United States (U.S.) Food and Drug Administration ...

In a startling pandemic preparedness development, Moderna yesterday announced that US Department of Health and Human Services ...

The Department of Health and Human Services cut over $750 million in funding for Moderna to develop an mRNA bird flu vaccine ...

The FDA has officially authorized the Novavax COVID-19 vaccine for emergency use in the U.S., and if you are skeptical of mRNA tech, this may be the perfect option. In fact, experts are hopeful that ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced its ...

CAMBRIDGE, MA / ACCESS Newswire / May 27, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the ...

Department of Cancer Biology, The University of Kansas Medical Center, Cancer Center, Kansas City, Kansas 66160, United States Center of BioModular Multi-Scale Systems for Precision Medicine, The ...

Maravai’s cash balance decreased to $285 million as of the end of the first quarter of 2025 from $322 million at the end of 2024. This decrease primarily stems from a free cash flow deficit of about ...

Roughly five months after AstraZeneca scrapped a major investment plan in its home country, the United Kingdom has found a ...

The researchers described the unprecedented speed of the oversight steps as being "through alternative procedures." In month ...

The baby boy received the bespoke therapy within a few months of birth and is doing well, according to a presentation at ASGCT.